IS5851A - Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja - Google Patents

Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja

Info

Publication number
IS5851A
IS5851A IS5851A IS5851A IS5851A IS 5851 A IS5851 A IS 5851A IS 5851 A IS5851 A IS 5851A IS 5851 A IS5851 A IS 5851A IS 5851 A IS5851 A IS 5851A
Authority
IS
Iceland
Prior art keywords
agents
antagonists
new oral
composition
oral
Prior art date
Application number
IS5851A
Other languages
English (en)
Other versions
IS2369B (is
Inventor
De Bruijn Karel
Engel Günter
Pfannkuche Hans-Jürgen
Thewissen Michael
Vitzling Christian
Züger Othmar
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451823&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5851(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9818340.3A external-priority patent/GB9818340D0/en
Priority claimed from GBGB9823477.6A external-priority patent/GB9823477D0/en
Priority claimed from GBGB9910320.2A external-priority patent/GB9910320D0/en
Priority claimed from GBGB9911059.5A external-priority patent/GB9911059D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS5851A publication Critical patent/IS5851A/is
Publication of IS2369B publication Critical patent/IS2369B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
IS5851A 1998-08-21 2000-02-20 Ný blanda 5-HT4 gerandefna eða mótlyfja til inntöku um munn IS2369B (is)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9818340.3A GB9818340D0 (en) 1998-08-21 1998-08-21 Organic compounds
GBGB9823477.6A GB9823477D0 (en) 1998-10-27 1998-10-27 Organic compounds
GBGB9910320.2A GB9910320D0 (en) 1999-05-05 1999-05-05 Organic compounds
GBGB9911059.5A GB9911059D0 (en) 1999-05-12 1999-05-12 Organic compounds
PCT/EP1999/006083 WO2000010526A2 (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists

Publications (2)

Publication Number Publication Date
IS5851A true IS5851A (is) 2001-01-20
IS2369B IS2369B (is) 2008-06-15

Family

ID=27451823

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5851A IS2369B (is) 1998-08-21 2000-02-20 Ný blanda 5-HT4 gerandefna eða mótlyfja til inntöku um munn

Country Status (30)

Country Link
US (4) US20030236183A1 (is)
EP (1) EP1104289B1 (is)
JP (1) JP4048024B2 (is)
KR (1) KR100529659B1 (is)
CN (2) CN1165293C (is)
AT (1) ATE316782T1 (is)
AU (4) AU762829B2 (is)
BG (1) BG65322B1 (is)
BR (1) BR9913135A (is)
CA (1) CA2338794C (is)
CZ (1) CZ300647B6 (is)
DE (1) DE69929703T2 (is)
DK (1) DK1104289T3 (is)
EE (1) EE05054B1 (is)
ES (1) ES2257869T3 (is)
FR (3) FR2782454B1 (is)
HK (1) HK1038179A1 (is)
HR (1) HRP20010123B1 (is)
HU (1) HU228179B1 (is)
ID (1) ID28510A (is)
IL (1) IL141236A0 (is)
IS (1) IS2369B (is)
IT (1) IT1314185B1 (is)
NO (1) NO328756B1 (is)
NZ (1) NZ509832A (is)
PL (2) PL200132B1 (is)
RS (1) RS50104B (is)
SK (1) SK285255B6 (is)
TR (3) TR200400187T2 (is)
WO (1) WO2000010526A2 (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743820B2 (en) 2000-07-07 2004-06-01 University Of Toledo Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
WO2002041918A2 (en) * 2000-11-24 2002-05-30 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
EP1598074B1 (en) * 2003-02-28 2019-01-02 Chugai Seiyaku Kabushiki Kaisha Stabilized protein-containing formulations
WO2004085393A1 (en) * 2003-03-25 2004-10-07 Hetero Drugs Limited Novel crystalline forms of tegaserod maleate
GB0307440D0 (en) * 2003-03-31 2003-05-07 Novartis Ag Organic compounds
PE20050253A1 (es) * 2003-07-24 2005-06-03 Novartis Ag Modificaciones estables de maleato de hidrogeno de tegaserod
US8591972B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for coated active components as part of an edible composition
US8591968B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Edible composition including a delivery system for active components
US8597703B2 (en) 2005-05-23 2013-12-03 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
US8591974B2 (en) 2003-11-21 2013-11-26 Kraft Foods Global Brands Llc Delivery system for two or more active components as part of an edible composition
US20050112236A1 (en) 2003-11-21 2005-05-26 Navroz Boghani Delivery system for active components as part of an edible composition having preselected tensile strength
US8389032B2 (en) 2005-05-23 2013-03-05 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition having selected particle size
US8591973B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
EP2493457B1 (en) 2009-10-30 2017-08-09 IX Biopharma Ltd Fast dissolving solid dosage form
WO2013026565A1 (de) 2011-08-20 2013-02-28 Advanced Medical Balloons Trans-analer einlaufkatheter und verfahren zur intermittierenden auslösung einer reflexkoordinierten defäkation
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US552398A (en) * 1895-12-31 Riveting-machine
JP2708803B2 (ja) * 1987-09-02 1998-02-04 中外製薬株式会社 持続放出製剤
ATE123237T1 (de) * 1990-08-24 1995-06-15 Spirig Ag Verfahren zur herstellung von pellets.
HUT64023A (en) * 1991-03-22 1993-11-29 Sandoz Ag Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
US5523289A (en) * 1991-04-15 1996-06-04 Abbott Laboratories Pharmaceutical composition
US20020128172A1 (en) * 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
FR2710915B1 (fr) * 1993-10-04 1995-11-24 Synthelabo Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
TW270114B (is) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5399562A (en) * 1994-02-04 1995-03-21 G. D. Searle & Co. Indolones useful as serotonergic agents
JPH0820586A (ja) * 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
MX9704079A (es) * 1994-12-01 1997-12-31 Cibus Pharmaceutical Inc Liberacion de farmacos antiinflamatorios no esteroides empleando uan goam hidrocoloide en polvo que se obtiene de plantas superiores.
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
JPH09194374A (ja) * 1995-11-14 1997-07-29 Taisho Pharmaceut Co Ltd 消化器疾患治療剤
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5739151A (en) * 1996-07-19 1998-04-14 Sepracor Inc. Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
FR2753196B1 (fr) * 1996-09-12 1998-10-23 Synthelabo Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof
US20010014352A1 (en) * 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod

Also Published As

Publication number Publication date
SK2432001A3 (en) 2001-09-11
ITMI991826A1 (it) 2001-02-19
PL346764A1 (en) 2002-02-25
HRP20010123A2 (en) 2002-02-28
CN1323200A (zh) 2001-11-21
TR200100361T2 (tr) 2001-06-21
IS2369B (is) 2008-06-15
FR2799123A1 (fr) 2001-04-06
NO328756B1 (no) 2010-05-03
KR100529659B1 (ko) 2005-11-21
RS50104B (sr) 2009-01-22
KR20010079668A (ko) 2001-08-22
DK1104289T3 (da) 2006-05-15
HUP0103431A3 (en) 2002-02-28
ES2257869T3 (es) 2006-08-01
ID28510A (id) 2001-05-31
EP1104289A2 (en) 2001-06-06
HRP20010123B1 (en) 2010-11-30
CN1165293C (zh) 2004-09-08
NO20010863L (no) 2001-03-26
CA2338794C (en) 2009-01-20
WO2000010526A3 (en) 2000-09-08
FR2782454B1 (fr) 2005-12-02
FR2784899B1 (fr) 2001-08-17
EP1104289B1 (en) 2006-02-01
ITMI991826A0 (it) 1999-08-19
BG105257A (en) 2001-11-30
AU2003248212A1 (en) 2003-10-30
US20120071537A1 (en) 2012-03-22
CA2338794A1 (en) 2000-03-02
AU5623299A (en) 2000-03-14
HK1038179A1 (en) 2002-03-08
FR2782454A1 (fr) 2000-02-25
WO2000010526A2 (en) 2000-03-02
FR2799123B1 (fr) 2005-12-02
CZ2001619A3 (en) 2001-05-16
BR9913135A (pt) 2001-05-08
US20030236183A1 (en) 2003-12-25
FR2784899A1 (fr) 2000-04-28
JP2002523351A (ja) 2002-07-30
PL194069B1 (pl) 2007-04-30
AU2009200403A1 (en) 2009-02-26
NZ509832A (en) 2003-11-28
BG65322B1 (bg) 2008-02-29
TR200102259T2 (tr) 2002-06-21
NO20010863D0 (no) 2001-02-20
AU762829B2 (en) 2003-07-03
IT1314185B1 (it) 2002-12-06
US20130158092A1 (en) 2013-06-20
EE05054B1 (et) 2008-08-15
ATE316782T1 (de) 2006-02-15
HU228179B1 (en) 2013-01-28
YU8701A (sh) 2003-12-31
PL200132B1 (pl) 2008-12-31
TR200400187T2 (tr) 2006-11-21
CZ300647B6 (cs) 2009-07-08
HUP0103431A2 (hu) 2002-01-28
IL141236A0 (en) 2002-03-10
DE69929703T2 (de) 2007-02-22
EE200100104A (et) 2002-06-17
SK285255B6 (sk) 2006-09-07
US20080075773A1 (en) 2008-03-27
DE69929703D1 (de) 2006-04-13
JP4048024B2 (ja) 2008-02-13
AU2006200048A1 (en) 2006-02-02
CN1589906A (zh) 2005-03-09

Similar Documents

Publication Publication Date Title
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
ATE495154T1 (de) Pharmazeutische zusammensetzungen, die ccr5- antagonisierende piperazinderivate enthalten
HUP0104987A3 (en) Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
ME00298B (me) Farmaceutski preparat
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
DE50115451D1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
HRP20010764B1 (en) Prucalopride oral solution
IS5390A (is) Bensoxazín og bensóþíazín afleiður og notkun þeirra í lyf
BR0010521A (pt) Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
MY152490A (en) New oral formulation
SE9803277D0 (sv) Novel compounds